您好,欢迎访问中国农业科学院 机构知识库!

Utilization of Native CRISPR-Cas9 System for Expression of Glucagon-like Peptide-1 in Lacticaseibacillus paracasei

文献类型: 外文期刊

作者: Zheng, Mumin 1 ; Zhang, Shuwen 1 ; Wang, Yunna 1 ; Xie, Ning 1 ; Wang, Xiaodan 1 ; Lv, Jiaping 1 ; Pang, Xiaoyang 1 ; Li, Xu 1 ;

作者机构: 1.Chinese Acad Agr Sci, Inst Food Sci & Technol, Key Lab Agroprod Qual & Safety Control Storage & T, Minist Agr & Rural Affairs, Beijing 100193, Peoples R China

关键词: Lacticaseibacillus paracasei; native CRISPR-Cas9; glucagon-like peptide-1 (GLP-1); genome editing; heterologous expression

期刊名称:FOODS ( 影响因子:5.1; 五年影响因子:5.6 )

ISSN:

年卷期: 2025 年 14 卷 10 期

页码:

收录情况: SCI

摘要: Type 2 diabetes is one of the main causes of cardiovascular diseases, kidney diseases, and visual impairments, posing a global healthcare challenge. The current treatment of this disease, involving glucagon-like peptide-1 (GLP-1), is faced with problems such as frequent injections and plasmid instability. In this study, we used the native clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) system of Lacticaseibacillus paracasei to develop a novel, genetically stable, and orally administrable strain expressing human GLP-1. Integration and subsequent expression of glp-1 gene were confirmed by genomic sequencing, qPCR, and Nano LC-MS. The engineered strain demonstrated stable genomic integration and sustained high-level expression of GLP-1 over multiple generations. This innovative approach provides a promising strategy for the oral delivery of therapeutic peptides, potentially enhancing patient compliance and improving the treatment of diabetes and other chronic diseases requiring peptide-based therapies.

  • 相关文献
作者其他论文 更多>>